 |
PDBsum entry 2fv5
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of tace in complex with ik682
|
|
Structure:
|
 |
Adam 17. Chain: a, b. Synonym: a disintegrin and metalloproteinase domain 17, tnf-alpha- converting enzyme, tnf-alpha convertase, snake venom-like protease, cd156b antigen. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: adam17, csvp, tace. Expressed in: trichoplusia ni. Expression_system_taxid: 7111
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.218
|
R-free:
|
0.256
|
|
|
Authors:
|
 |
P.Orth,X.Niu
|
|
Key ref:
|
 |
X.Niu
et al.
(2006).
IK682, a tight binding inhibitor of TACE.
Arch Biochem Biophys,
451,
43-50.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-Jan-06
|
Release date:
|
04-Jul-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P78536
(ADA17_HUMAN) -
Disintegrin and metalloproteinase domain-containing protein 17 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
824 a.a.
261 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 4 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.86
- Adam 17 endopeptidase.
|
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Arch Biochem Biophys
451:43-50
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
IK682, a tight binding inhibitor of TACE.
|
|
X.Niu,
S.Umland,
R.Ingram,
B.M.Beyer,
Y.H.Liu,
J.Sun,
D.Lundell,
P.Orth.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
TNFalpha converting enzyme (TACE) is the major metalloproteinase for the
processing of TNFalpha, a key inflammatory cytokine. IK682, a hydroxamate
compound, was reported to be a potent and specific TACE inhibitor [J.J. Duan, L.
Chen, Z.R. Wasserman, Z. Lu, R.Q. Liu, M.B. Covington, M. Qian, K.D. Hardman,
R.L. Magolda, R.C. Newton, D.D. Christ, R.R. Wexler, C.P. Decicco, J. Med. Chem.
45 (2002) 4954-4957]. The binding kinetics of IK682 and the ectodomain of human
TACE was examined. The k(on) of IK682 was determined as 1.1+/-0.3 x 10(8) M(-1)
min(-1). No detectable dissociation of IK682 from TACE was observed following
dialysis, dilution, and extensive washing over a maximum of 72 h. This was in
contrast to the rapid dissociation of IK682 from ADAM10. LC/MS analysis of the
TACE-IK682 complex after dissociation under denaturing conditions indicated that
the tight binding is not due to covalent interaction. The X-ray crystal
structure of TACE-IK682 complex revealed multiple binding points at the S1' and
S3' sites and the movement of a loop (from Ala349 to Gly442) to accommodate the
binding of the quinolinyl group of IK682 at the S3' pocket. The conformational
changes of TACE may contribute significantly to the high affinity binding as a
result of a more stable TACE-inhibitor complex.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Zhao,
J.Yu,
J.Gu,
and
W.Huang
(2011).
The evaluation of inhibitive effectiveness of the tumour necrosis factor-α converting enzyme selective inhibitors by HPLC.
|
| |
J Enzyme Inhib Med Chem,
26,
181-187.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |